Literature DB >> 7749193

Cell cycle regulation of a Xenopus Wee1-like kinase.

P R Mueller1, T R Coleman, W G Dunphy.   

Abstract

Using a polymerase chain reaction-based strategy, we have isolated a gene encoding a Wee1-like kinase from Xenopus eggs. The recombinant Xenopus Wee1 protein efficiently phosphorylates Cdc2 exclusively on Tyr-15 in a cyclin-dependent manner. The addition of exogenous Wee1 protein to Xenopus cell cycle extracts results in a dose-dependent delay of mitotic initiation that is accompanied by enhanced tyrosine phosphorylation of Cdc2. The activity of the Wee1 protein is highly regulated during the cell cycle: the interphase, underphosphorylated form of Wee1 (68 kDa) phosphorylates Cdc2 very efficiently, whereas the mitotic, hyperphosphorylated version (75 kDa) is weakly active as a Cdc2-specific tyrosine kinase. The down-modulation of Wee1 at mitosis is directly attributable to phosphorylation, since dephosphorylation with protein phosphatase 2A restores its kinase activity. During interphase, the activity of this Wee1 homolog does not vary in response to the presence of unreplicated DNA. The mitosis-specific phosphorylation of Wee1 is due to at least two distinct kinases: the Cdc2 protein and another activity (kinase X) that may correspond to an MPM-2 epitope kinase. These studies indicate that the down-regulation of Wee1-like kinase activity at mitosis is a multistep process that occurs after other biochemical reactions have signaled the successful completion of S phase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749193      PMCID: PMC275819          DOI: 10.1091/mbc.6.1.119

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  52 in total

1.  Genetic control of cell size at cell division in yeast.

Authors:  P Nurse
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

2.  Coupling of mitosis to the completion of S phase in Xenopus occurs via modulation of the tyrosine kinase that phosphorylates p34cdc2.

Authors:  C Smythe; J W Newport
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

3.  Regulation of the cdc25 protein during the cell cycle in Xenopus extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

4.  The cdc25 protein contains an intrinsic phosphatase activity.

Authors:  W G Dunphy; A Kumagai
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

5.  Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication.

Authors:  T Enoch; P Nurse
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

6.  Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer.

Authors:  T R Coleman; Z Tang; W G Dunphy
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog.

Authors:  P Russell; P Nurse
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

8.  The decision to enter mitosis.

Authors:  W G Dunphy
Journal:  Trends Cell Biol       Date:  1994-06       Impact factor: 20.808

9.  Properties of Saccharomyces cerevisiae wee1 and its differential regulation of p34CDC28 in response to G1 and G2 cyclins.

Authors:  R N Booher; R J Deshaies; M W Kirschner
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

10.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  122 in total

1.  DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding.

Authors:  Y Zeng; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Absence of Wee1 ensures the meiotic cell cycle in Xenopus oocytes.

Authors:  N Nakajo; S Yoshitome; J Iwashita; M Iida; K Uto; S Ueno; K Okamoto; N Sagata
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 3.  Triggering the all-or-nothing switch into mitosis.

Authors:  P H O'Farrell
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

4.  Residual Cdc2 activity remaining at meiosis I exit is essential for meiotic M-M transition in Xenopus oocyte extracts.

Authors:  M Iwabuchi; K Ohsumi; T M Yamamoto; W Sawada; T Kishimoto
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

5.  Nif1, a novel mitotic inhibitor in Schizosaccharomyces pombe.

Authors:  L Wu; P Russell
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

6.  Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.

Authors:  I Vincent; G Jicha; M Rosado; D W Dickson
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

7.  Schizosaccharomyces pombe NIMA-related kinase, Fin1, regulates spindle formation and an affinity of Polo for the SPB.

Authors:  Agnes Grallert; Iain M Hagan
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

8.  Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts.

Authors:  Wei Sha; Jonathan Moore; Katherine Chen; Antonio D Lassaletta; Chung-Seon Yi; John J Tyson; Jill C Sible
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

9.  A framework for image-based classification of mitotic cells in asynchronous populations.

Authors:  Scott D Slattery; Justin Y Newberg; Adam T Szafran; Rebecca M Hall; Bill R Brinkley; Michael A Mancini
Journal:  Assay Drug Dev Technol       Date:  2011-11-15       Impact factor: 1.738

10.  Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.

Authors:  James R A Hutchins; Dina Dikovskaya; Paul R Clarke
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.